PHBI Pharmgreen Launches Online Sales for Its MaxGenomic™ Supplement Product

February 8, 2023

CARSON CITY, NV, Feb. 08, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), “Pharmagreen” or the “Company” is pleased to announce that it has completed development of its first formulated nutraceutical product and has commenced online sales via the Shopify ecommerce platform of its MaxGenomic™ Supplement.  The company is also pleased to have entered the nutraceutical industry with this product development and be part of this multi-hundred-billion-dollar industry that is growing at a record pace.

Read more at globenewswire.com

Related news for (PHBI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.